Numab ^None

Numab is a biotechnology company that specializes in developing antibody-based therapeutics for the treatment of chronic inflammation and cancer. They have a plug-and-play platform that reduces the randomness of the discovery process and yields ready-to-develop multispecific biotherapeutics. Numab is an oncology-focused biopharmaceutical company.